Effects of α4β2 and α7 nicotinic acetylcholine receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats

Seiki Motoshima, Katsuya Suemaru, Youichi Kawasaki, Chunyu Jin, Hiromu Kawasaki, Yutaka Gomita, Hiroaki Araki

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Acute dependence can be observed when naloxone is administered 24 h after even a single dose of morphine, and nicotine attenuates this naloxone-precipitated withdrawal syndrome. This acute dependence has been hypothesized to be associated with a dopaminergic mechanism. In the present study, the role of nicotinic acetylcholine receptor subtypes in the place aversion induced by naloxone in single-dose morphine-treated rats was investigated. Methyllycaconitine (1, 2 and 5 mg/kg), an α7 nicotinic acetylcholine receptor subtype inhibitor, significantly and dose dependently inhibited the attenuating effect of nicotine on naloxone-induced place aversion. In contrast, dihydroxy-β-erithroidine (1, 2 and 5 mg/kg), an α4β2 nicotinic acetylcholine receptor subtype inhibitor, did not have any effect on the attenuating effect of nicotine on naloxone-induced place aversion. These findings suggested that the α7 nicotinic acetylcholine receptor subtype is associated with the place aversion induced by naloxone in single-dose morphine-treated rats. Nicotinic acetylcholine receptor subtype inhibitors warrant further study as possible treatment for acute dependence.

Original languageEnglish
Pages (from-to)91-95
Number of pages5
JournalEuropean Journal of Pharmacology
Volume519
Issue number1-2
DOIs
Publication statusPublished - Sep 5 2005

Fingerprint

Nicotinic Receptors
Cholinergic Antagonists
Naloxone
Morphine
Nicotine

Keywords

  • αβ Nicotinic acetylcholine receptor subtype
  • α Nicotinic acetylcholine receptor subtype
  • Morphine
  • Naloxone
  • Place aversion

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Effects of α4β2 and α7 nicotinic acetylcholine receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats. / Motoshima, Seiki; Suemaru, Katsuya; Kawasaki, Youichi; Jin, Chunyu; Kawasaki, Hiromu; Gomita, Yutaka; Araki, Hiroaki.

In: European Journal of Pharmacology, Vol. 519, No. 1-2, 05.09.2005, p. 91-95.

Research output: Contribution to journalArticle

Motoshima, Seiki ; Suemaru, Katsuya ; Kawasaki, Youichi ; Jin, Chunyu ; Kawasaki, Hiromu ; Gomita, Yutaka ; Araki, Hiroaki. / Effects of α4β2 and α7 nicotinic acetylcholine receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats. In: European Journal of Pharmacology. 2005 ; Vol. 519, No. 1-2. pp. 91-95.
@article{69f3182a5048452a9c2a3ee90475c25f,
title = "Effects of α4β2 and α7 nicotinic acetylcholine receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats",
abstract = "Acute dependence can be observed when naloxone is administered 24 h after even a single dose of morphine, and nicotine attenuates this naloxone-precipitated withdrawal syndrome. This acute dependence has been hypothesized to be associated with a dopaminergic mechanism. In the present study, the role of nicotinic acetylcholine receptor subtypes in the place aversion induced by naloxone in single-dose morphine-treated rats was investigated. Methyllycaconitine (1, 2 and 5 mg/kg), an α7 nicotinic acetylcholine receptor subtype inhibitor, significantly and dose dependently inhibited the attenuating effect of nicotine on naloxone-induced place aversion. In contrast, dihydroxy-β-erithroidine (1, 2 and 5 mg/kg), an α4β2 nicotinic acetylcholine receptor subtype inhibitor, did not have any effect on the attenuating effect of nicotine on naloxone-induced place aversion. These findings suggested that the α7 nicotinic acetylcholine receptor subtype is associated with the place aversion induced by naloxone in single-dose morphine-treated rats. Nicotinic acetylcholine receptor subtype inhibitors warrant further study as possible treatment for acute dependence.",
keywords = "αβ Nicotinic acetylcholine receptor subtype, α Nicotinic acetylcholine receptor subtype, Morphine, Naloxone, Place aversion",
author = "Seiki Motoshima and Katsuya Suemaru and Youichi Kawasaki and Chunyu Jin and Hiromu Kawasaki and Yutaka Gomita and Hiroaki Araki",
year = "2005",
month = "9",
day = "5",
doi = "10.1016/j.ejphar.2005.06.050",
language = "English",
volume = "519",
pages = "91--95",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Effects of α4β2 and α7 nicotinic acetylcholine receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats

AU - Motoshima, Seiki

AU - Suemaru, Katsuya

AU - Kawasaki, Youichi

AU - Jin, Chunyu

AU - Kawasaki, Hiromu

AU - Gomita, Yutaka

AU - Araki, Hiroaki

PY - 2005/9/5

Y1 - 2005/9/5

N2 - Acute dependence can be observed when naloxone is administered 24 h after even a single dose of morphine, and nicotine attenuates this naloxone-precipitated withdrawal syndrome. This acute dependence has been hypothesized to be associated with a dopaminergic mechanism. In the present study, the role of nicotinic acetylcholine receptor subtypes in the place aversion induced by naloxone in single-dose morphine-treated rats was investigated. Methyllycaconitine (1, 2 and 5 mg/kg), an α7 nicotinic acetylcholine receptor subtype inhibitor, significantly and dose dependently inhibited the attenuating effect of nicotine on naloxone-induced place aversion. In contrast, dihydroxy-β-erithroidine (1, 2 and 5 mg/kg), an α4β2 nicotinic acetylcholine receptor subtype inhibitor, did not have any effect on the attenuating effect of nicotine on naloxone-induced place aversion. These findings suggested that the α7 nicotinic acetylcholine receptor subtype is associated with the place aversion induced by naloxone in single-dose morphine-treated rats. Nicotinic acetylcholine receptor subtype inhibitors warrant further study as possible treatment for acute dependence.

AB - Acute dependence can be observed when naloxone is administered 24 h after even a single dose of morphine, and nicotine attenuates this naloxone-precipitated withdrawal syndrome. This acute dependence has been hypothesized to be associated with a dopaminergic mechanism. In the present study, the role of nicotinic acetylcholine receptor subtypes in the place aversion induced by naloxone in single-dose morphine-treated rats was investigated. Methyllycaconitine (1, 2 and 5 mg/kg), an α7 nicotinic acetylcholine receptor subtype inhibitor, significantly and dose dependently inhibited the attenuating effect of nicotine on naloxone-induced place aversion. In contrast, dihydroxy-β-erithroidine (1, 2 and 5 mg/kg), an α4β2 nicotinic acetylcholine receptor subtype inhibitor, did not have any effect on the attenuating effect of nicotine on naloxone-induced place aversion. These findings suggested that the α7 nicotinic acetylcholine receptor subtype is associated with the place aversion induced by naloxone in single-dose morphine-treated rats. Nicotinic acetylcholine receptor subtype inhibitors warrant further study as possible treatment for acute dependence.

KW - αβ Nicotinic acetylcholine receptor subtype

KW - α Nicotinic acetylcholine receptor subtype

KW - Morphine

KW - Naloxone

KW - Place aversion

UR - http://www.scopus.com/inward/record.url?scp=27744489339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744489339&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2005.06.050

DO - 10.1016/j.ejphar.2005.06.050

M3 - Article

C2 - 16098507

AN - SCOPUS:27744489339

VL - 519

SP - 91

EP - 95

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-2

ER -